UK-based startup developing a data-rich AI platform to discover and design next-generation enzymes
Scindo has raised €4.5M across 1 funding round from 8 investors, most recently a round in Sep 2025. Based in London, UK; active in Software. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-23 | Other | €4.5M |
| AgFunder,Clay Capital,Farvatn Venture,Kadmos Capital,PINC,Savantus Ventures+2 more |
| View deal → |
